Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
暂无分享,去创建一个
Heinz Feldmann | Lisa E. Hensley | H. Feldmann | L. Hensley | T. Geisbert | A. Leung | J. Geisbert | A. Grolla | Thomas W. Geisbert | Joan B. Geisbert | Allen Grolla | Anders Leung | Kathleen M. Daddario-DiCaprio | Anders Leung
[1] P Brès,et al. [The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note]. , 1978, Bulletin of the World Health Organization.
[2] D. Cyranoski. Ebola outbreak has experts rooting for answers , 2009, Nature.
[3] B. Murphy,et al. Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus , 2007, Journal of Virology.
[4] Jon Cohen. Did Merck's Failed HIV Vaccine Cause Harm? , 2007, Science.
[5] B. Ramsey,et al. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. , 1998, Pediatrics.
[6] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[7] R. Koup,et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates , 2003, Nature.
[8] D. Dichek,et al. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. , 1997, The Journal of clinical investigation.
[9] D. Normile. Scientists Puzzle Over Ebola-Reston Virus in Pigs , 2009, Science.
[10] R. Chanock,et al. Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. , 1969, American journal of epidemiology.
[11] B. Mothé,et al. Development of a New Vaccine for the Prevention of Lassa Fever , 2005, PLoS medicine.
[12] L. Fernando,et al. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment , 2006, The Lancet.
[13] A. Sanchez,et al. Development of a preventive vaccine for Ebola virus infection in primates , 2000, Nature.
[14] R. Koup,et al. Competing Interests: GJN: , 2022 .
[15] Heinz Feldmann,et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses , 2005, Nature Medicine.
[16] P. Formenty,et al. Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2 , 2007, The Journal of infectious diseases.
[17] C. Boesch,et al. Isolation and partial characterisation of a new strain of Ebola virus , 1995, The Lancet.
[18] K. Johnson,et al. MARBURG-VIRUS DISEASE IN KENYA , 1982, The Lancet.
[19] H. Feldmann,et al. Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine , 2006, Journal of Virology.
[20] H. Feldmann,et al. Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses , 2004, Journal of Virology.
[21] Steven J M Jones,et al. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. , 2008, Vaccine.
[22] W. Ian Lipkin,et al. Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda , 2008, PLoS pathogens.
[23] J. Maniloff,et al. Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses , 2005 .
[24] Steven J M Jones,et al. Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates , 2008, PLoS pathogens.
[25] S. Hazar,et al. Filoviridae: Marburg and Ebola viruses. , 2000 .
[26] W. Kalina,et al. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. , 2007, The Journal of infectious diseases.
[27] D. Swenson,et al. Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections , 2008, Clinical and Vaccine Immunology.
[28] L. Fernando,et al. Effective Post-Exposure Treatment of Ebola Infection , 2007, PLoS pathogens.
[29] D. Simpson,et al. A comparative study of strains of ebola virus isolated from southern sudan and northern zaire in 1976 , 1980, Journal of medical virology.
[30] J. A. Comer,et al. Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola , 2006, Journal of Virology.
[31] R. Sékaly. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.
[32] H. Feldmann,et al. Marburg and Ebola viruses. , 1996, Advances in virus research.
[33] H. Feldmann,et al. Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates , 2008, Journal of Virology.
[34] J. Smith,et al. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. , 1998, Virology.
[35] P. Jahrling,et al. Filovirus Pathogenesis in Nonhuman Primates , 2002 .
[36] P. Jahrling,et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. , 1999, The Journal of infectious diseases.